nfin Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$1.07M
- Investors
-
11
nfin General Information
Description
Operator of a protein manufacturing platform intended to accelerate the prototyping and production of engineered proteins. The company uses engineered production cells to rapidly manufacture protein designs and generate experimental data, enabling protein designers to validate designs, improve predictive models, and scale promising candidates toward production.
Contact Information
Website
nfin.bioCorporate Office
- Imperial College London
- South Kensington Campus
- London SW7 2AZ
- England, United Kingdom
Corporate Office
- Imperial College London
- South Kensington Campus
- London SW7 2AZ
- England, United Kingdom
nfin Timeline
nfin Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Grant | 10-Aug-2026 | $1.07M | Completed | Generating Revenue | ||
| 9. Seed Round | 01-Dec-2024 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | 17-Jun-2024 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 01-Jan-2024 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 01-Jan-2024 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 01-Aug-2023 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 3. Grant | 01-Aug-2023 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
nfin Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
nfin Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
nfin Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Advanced Research + Invention Agency | Government | |||
| BlueYard Capital | Venture Capital | Minority | ||
| CPT Capital | Venture Capital | Minority | ||
| EIT Food | Accelerator/Incubator | |||
| MassChallenge | Accelerator/Incubator |
nfin FAQs
-
When was nfin founded?
nfin was founded in 2023.
-
Where is nfin headquartered?
nfin is headquartered in London, United Kingdom.
-
What is the size of nfin?
nfin has 2 total employees.
-
What industry is nfin in?
nfin’s primary industry is Biotechnology.
-
Is nfin a private or public company?
nfin is a Private company.
-
What is nfin’s current revenue?
The current revenue for nfin is .
-
How much funding has nfin raised over time?
nfin has raised $519K.
-
Who are nfin’s investors?
Advanced Research + Invention Agency, BlueYard Capital, CPT Capital, EIT Food, and MassChallenge are 5 of 11 investors who have invested in nfin.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
